U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival

positivelysharing

4 years ago

Reading Time: < 1 minute

Gilead Sciences and GlaxoSmithKline subsidiary ViiV Healthcare are entangled in a heated race for HIV market share, Read More